References
1. Yadav RS, Jayswal A, Shrestha S, Gupta SK, Paudel U. Dystrophic Epidermolysis Bullosa. JNMA; journal of the Nepal Medical Association. 2018;56(213):879-82.
2. Boeira VL, Souza ES, Rocha Bde O, Oliveira PD, Oliveira Mde F, Rego VR, et al. Inherited epidermolysis bullosa: clinical and therapeutic aspects. An Bras Dermatol. 2013;88(2):185-98.
3. Has C, Nystrom A, Saeidian AH, Bruckner-Tuderman L, Uitto J. Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone. Matrix biology : journal of the International Society for Matrix Biology. 2018;71-72:313-29.
4. Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Experimental dermatology. 2008;17(7):553-68.
5. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2009;25(14):1754-60.
6. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research. 2010;20(9):1297-303.
7. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research. 2010;38(16):e164.
8. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nature Methods. 2014;11(4):361-2.
9. Ryynanen M, Ryynanen J, Sollberg S, Iozzo RV, Knowlton RG, Uitto J. Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. The Journal of clinical investigation. 1992;89(3):974-80.
10. Greenspan DS, Byers MG, Eddy RL, Hoffman GG, Shows TB. Localization of the human collagen gene COL7A1 to 3p21.3 by fluorescence in situ hybridization. Cytogenetic and Genome Research. 1993;62(1):35-6.
11. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix biology : journal of the International Society for Matrix Biology. 1999;18(1):43-54.
12. Frew J, Lim SW, Klausseger A, Chow CW, Tran K, Su J, et al. Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen. The Australasian journal of dermatology. 2011;52(4):e1-4.
13. Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C. Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. The Journal of investigative dermatology. 2006;126(5):1006-12.
14. Posteraro P, Pascucci M, Colombi M, Barlati S, Giannetti A, Paradisi M, et al. Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa. Biochemical and biophysical research communications. 2005;338(3):1391-401.
15. Gardella R, Castiglia D, Posteraro P, Bernardini S, Zoppi N, Paradisi M, et al. Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa. The Journal of investigative dermatology. 2002;119(6):1456-62.
16. Matsuba S, Suga Y, Mayuzumi N, Ikeda S, Ogawa H. A Japanese case of de novo dominant dystrophic epidermolysis bullosa. Clinical and experimental dermatology. 2002;27(1):56-8.
17. Murata T, Masunaga T, Shimizu H, Takizawa Y, Ishiko A, Hatta N, et al. Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa. Archives of dermatological research. 2000;292(10):477-81.
18. Mecklenbeck S, Hammami-Hauasli N, Hopfner B, Schumann H, Kramer A, Kuster W, et al. Clustering of COL7A1 mutations in exon 73: implications for mutation analysis in dystrophic epidermolysis bullosa. The Journal of investigative dermatology. 1999;112(3):398-400.
19. Rouan F, Pulkkinen L, Jonkman MF, Bauer JW, Cserhalmi-Friedman PB, Christiano AM, et al. Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling. The Journal of investigative dermatology. 1998;111(6):1210-3.
20. Kon A, Nomura K, Pulkkinen L, Sawamura D, Hashimoto I, Uitto J. Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic. The Journal of investigative dermatology. 1997;109(5):684-7.
21. Kon A, McGrath JA, Pulkkinen L, Nomura K, Nakamura T, Maekawa Y, et al. Glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling. The Journal of investigative dermatology. 1997;108(2):224-8.
22. Cserhalmi-Friedman PB, Grossman J, Karpati S, Ahmad W, Horvath A, Christiano AM. Identification of a de novo glycine substitution in the type VII collagen gene in a proband with mild dystrophic epidermolysis bullosa. Experimental dermatology. 1999;8(2):143-5.
23. Gardella R, Belletti L, Zoppi N, Marini D, Barlati S, Colombi M. Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. American journal of human genetics. 1996;59(2):292-300.
24. Strachan T, Goodship J, Chinnery P. Genetics and genomics in medicine: Taylor & Francis; 2014.
25. Drera B, Ritelli M, Tadini G, Zoppi N, Venturini M, Calzavara-Pinton PG, et al. The novel p.G150R missense mutation in the cartilage matrix protein subdomain of type VII collagen in compound heterozigosity with the c.682+1G>A COL7A1 splicing mutation leads to mild dystrophic epidermolysis bullosa. Journal of dermatological science. 2009;53(3):222-5.